176 related articles for article (PubMed ID: 6247586)
1. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
Lerner U; Gustafson GT
Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
[TBL] [Abstract][Full Text] [Related]
2. Delayed stimulation of bone resorption in vitro by phosphodiesterase inhibitors requires the presence of adenylate cyclase stimulation.
Ransjö M; Fredholm BB; Lerner UH
Bone Miner; 1988 Jan; 3(3):225-34. PubMed ID: 2462948
[TBL] [Abstract][Full Text] [Related]
3. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
4. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
Ransjö M; Lerner UH
Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
Lerner UH; Ransjö M; Ljunggren O
Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of the effects of cyclic nucleotide phosphodiesterase inhibitors on bone resorption and cyclic AMP formation in vitro.
Lerner U; Ransjö M; Fredholm BB
Biochem Pharmacol; 1986 Dec; 35(23):4177-89. PubMed ID: 2431692
[TBL] [Abstract][Full Text] [Related]
7. Use of forskolin to study the relationship between cyclic AMP formation and bone resorption in vitro.
Lerner UH; Fredholm BB; Ransjö M
Biochem J; 1986 Dec; 240(2):529-39. PubMed ID: 3028378
[TBL] [Abstract][Full Text] [Related]
8. The cyclic-AMP antagonist adenosine-3',5'-cyclic monophosphosphorothioate, RP-isomer inhibits parathyroid hormone induced bone resorption, in vitro.
Ljunggren O; Ljunghall S
Biochem Biophys Res Commun; 1993 Jun; 193(3):821-6. PubMed ID: 8391806
[TBL] [Abstract][Full Text] [Related]
9. The effect of dibutyryl cyclic AMP and PGE2 on lysosomal enzyme release and lactate production in relation to bone resorption in vitro.
Lerner U
Acta Physiol Scand; 1980 Oct; 110(2):123-30. PubMed ID: 6259883
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of bone resorption and lysosomal enzyme release from calvarial bones cultured for 24 hours: synergism between cyclic AMP analogues and phosphodiesterase inhibitors.
Lerner U
Acta Endocrinol (Copenh); 1980 May; 94(1):138-44. PubMed ID: 6155751
[No Abstract] [Full Text] [Related]
11. In vitro studies on bone resorption in neonatal mouse calvariae using a modified dissection technique giving four samples of bone from each calvaria.
Ljunggren O; Ransjö M; Lerner UH
J Bone Miner Res; 1991 Jun; 6(6):543-50. PubMed ID: 1887817
[TBL] [Abstract][Full Text] [Related]
12. Delayed stimulatory effect of cyclic AMP on bone resorption in vitro.
Lerner U; Gustafson GT
Acta Endocrinol (Copenh); 1981 Jun; 97(2):281-8. PubMed ID: 6165208
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effect of dibutyryl cyclic AMP on the release of calcium, inorganic phosphate and lysosomal enzymes from calvarial bones cultured for 24 hours.
Lerner U; Gustafson GT
Acta Endocrinol (Copenh); 1979 Aug; 91(4):730-42. PubMed ID: 227206
[TBL] [Abstract][Full Text] [Related]
14. Evidence for multiple bone resorption-stimulating factors produced by normal human keratinocytes in culture.
Fried RM; Voelkel EF; Rice RH; Levine L; Tashjian AH
Endocrinology; 1988 Jun; 122(6):2467-75. PubMed ID: 2453341
[TBL] [Abstract][Full Text] [Related]
15. Influence of diphenylhydantoin on lysosomal enzyme release during bone resorption in vitro.
Lerner U; Hänström L
Acta Pharmacol Toxicol (Copenh); 1980 Aug; 47(2):144-50. PubMed ID: 6776782
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin E2 stimulates the formation of mineralized bone nodules by a cAMP-independent mechanism in the culture of adult rat calvarial osteoblasts.
Kaneki H; Takasugi I; Fujieda M; Kiriu M; Mizuochi S; Ide H
J Cell Biochem; 1999 Apr; 73(1):36-48. PubMed ID: 10088722
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
Lerner UH; Gustafson GT
Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
[TBL] [Abstract][Full Text] [Related]
18. Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption.
Lerner UH
J Bone Miner Res; 1987 Oct; 2(5):375-83. PubMed ID: 3455622
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin stimulates bone resorption and lysosomal-enzyme release in cultured mouse calvaria.
Gustafson GT; Lerner U
Biochem J; 1984 Apr; 219(1):329-32. PubMed ID: 6721862
[TBL] [Abstract][Full Text] [Related]
20. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
Lerner UH; Larsson A
Bone; 1987; 8(3):179-89. PubMed ID: 2955802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
